Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-08

Clinical Trial Update: Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan, fluorouracil, and leucovorin with or without zibotentan for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUOROURACIL (Fluorouracil)
  • IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)
  • Leucovorin calcium (calcium folinate)
  • Zibotentan (zibotentan)

Snippet

Sponsor: Cardiff University | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED